Clinical Trial Update: Docetaxel and S-1 for Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of docetaxel and S-1 for advanced esophageal cancer; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Hallym University Medical Center | Conditions: Esophageal Neoplasms | Phase 2 | Status: UNKNOWN